Transplant Surgery · Houston, TX
NPI
1326072604
Since 2006
Specialty
Transplant Surgery
Code 204F00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
6550 Fannin St, Suite 1601
Houston, TX, 77030
Phone (713) 441-5141
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
37 services
Medicare patients, 2024
18
Average age 67
Drug cost, 2024
$288K
2,562 prescriptions
Company payments, 2025
$13K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rafik M Ghobrial M.D. was code 47135 (digestive/gastrointestinal), 15 times for 15 patients. In total Rafik M Ghobrial M.D. billed 37 services in 9 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-01-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 47135 Digestive/Gastrointestinal | Facility | 15 | 15 | $1,221.42 | $18K |
| 47143 Digestive/Gastrointestinal | Facility | 13 | 13 | $48.08 | $625 |
By year: 2022 $53K for 48 services; 2023 $20K for 30 services; 2024 $20K for 37 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rafik M Ghobrial M.D. prescribed most often to Medicare patients was Ursodiol, with 428 prescriptions and refills. In total Rafik M Ghobrial M.D. wrote 2,562 Medicare prescriptions that cost $288K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ursodiol Generic | 428 | 589 | 133 | $31K |
| Pantoprazole Sodium Generic | 344 | 539 | 114 | $1,991 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 297 | 427 | 89 | $1,130 |
| Tacrolimus Generic | 159 | 239 | 54 | $29K |
| Valganciclovir Hcl Generic | 157 | 209 | 76 | $24K |
| Prednisone Generic | 104 | 155 | 47 | $1,228 |
| Amlodipine Besylate Generic | 98 | 136 | 28 | $287 |
| Mycophenolate Mofetil Generic | 78 | 121 | 38 | $9,661 |
| Voriconazole Generic | 73 | 98 | 41 | $36K |
| Levothyroxine Sodium Generic | 56 | 74 | 21 | $284 |
| Atovaquone Generic | 55 | 65 | 22 | $29K |
| Gabapentin Generic | 46 | 61 | 30 | $239 |
| Entecavir Generic | 44 | 77 | 15 | $4,908 |
| Fluconazole Generic | 43 | 64 | 25 | $3,005 |
| Carvedilol Generic | 36 | 60 | 16 | $154 |
Brand drugs: 79 claims; generic drugs: 2,483 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rafik M Ghobrial M.D. $13K ($13K in general payments such as food, travel and fees) from 13 companies. The largest payer was Sanofi-Aventis U.S. LLC with $5,309.
| Company | Payments | Amount |
|---|---|---|
| Sanofi-Aventis U.S. LLC SNY | 3 | $5,309 |
| Genzyme Corporation SNY | 1 | $4,375 |
| Sanofi US Services Inc. SNY | 2 | $2,625 |
| Gilead Sciences, Inc. GILD | 11 | $239 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $120 |
| Surgical Specialties Corporation (us), Inc. (dba Corza Medical) | 1 | $106 |
| Madrigal Pharmaceuticals MDGL | 4 | $63.94 |
| Baxter Healthcare BAX | 1 | $42.81 |
| Intercept Pharmaceuticals, Inc. | 2 | $37.92 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $37.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.